Skip to main content

Publications

69 publications

Active

4 grants
  • PI
    Humanization of the bone marrow vascular niche to study hematopoietic stem cell and vascular interactionsand function
    NHLBI · 2026–2030 · via NIH RePORTER
    R01HL185875-01
  • PI
    Netrin-1 promotes the expansion and function of human hematopoietic stem cells by supporting a pro-hematopoietic vascular niche
    NHLBI · 2025–2027 · via NIH RePORTER
    R01HL177599-02
  • PI
    Preserving bone marrow niche integrity and function to rejuvenate aged hematopoietic stem cells
    NHLBI · 2023–2027 · via NIH RePORTER
    R01HL166512-04
  • PI
    Rejuvenation of aged hematopoietic stem cells and endothelial niches by thrombospondin-1 blockade
    NIA · 2019–2026 · via NIH RePORTER
    R01AG065436-06
Completed grants (11)
  • PI
    mTOR Dependent Regulation of Hematopoietic Stem Cell Aging and Longevity
    NIA · 2021–2022 · via NIH RePORTER
    R56AG073379-01
  • Co-I
    Vascular Niche Platform to Expand Hematopoietic Stem and Progenitor Cells Engineered to Cure Sickle Cell Disease
    New York State Stem Cell Science (NYSTEM) · 2015–2020
    C0 30160
  • PI
    Alterations in Endothelial-Mitochondrial UPR Signaling Drives Hematopoietic Stem Cell Aging
    Tri-Institutional Stem Cell Initiative (Weill Cornell) · 2016–2019
    TRI-SCI 2016-010
  • PI
    Endothelial mTOR Signaling Regulates Hematopoietic Stem Cell Aging
    Tri-Institutional Stem Cell Initiative (Weill Cornell) · 2014–2018
    2014-004
  • PI
    Rejuvenation of Aged Vascular Niches to Enhance Hematopoietic Function and Treat Hematopoietic Malignancies
    Leukemia & Lymphoma Society · 2017–2018
    R0859-18
  • PI
    Modulating Endothelial-Specific Signaling to Enhance Funtional Hematopoiesis.
    National Heart, Lung, and Blood Institute · 2016–2018
    R01HL133021-02
  • PI
    Modulating Signaling Pathways in Endothelial Cells to Abate Leukemic Progression
    National Cancer Institute · 2016–2018
    R01CA204308-03
  • Co-I
    A Shared Facility for the Derivation, Validation, and Distribution of Stem Cells for Disease Modeling
    New York State Stem Cell Science (NYSTEM) · 2014–2018
    C029156
  • KP
    Pluripotent Stem Cell Therapies for Genetic Diseases
    National Heart, Lung, and Blood Institute · 2013–2017 · via Fred Hutchinson Cancer Research Center
    R01HL115128-04
  • KP
    NHLBI Progenitor Cell Biology Consortium Administrative Coordinating Center
    National Heart, Lung, and Blood Institute · 2013–2015 · via University of Maryland, Baltimore
    U01HL099997-06 EW
  • KP
    Contribution of the Vascular Niche to the Hematopoietic Reconstitution
    National Heart, Lung, and Blood Institute · 2009–2013
    R01HL097797-02